Biocurex, Inc. (BOCX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss for the period	-2.57M
Accretion of discounts on debt
Allowance for uncollectible notes receivable	0
Amortization of patents
Amortization of debt issue costs	24.27K
Gain on extinguishments of debt
Gain on write off accounts payable
Loss (gain) on sale of investment securities	0
Loss from impairment of patents	0
Gain (loss) on derivative liability	-25.37K
Stock-based compensation	516.58K
Notes and interest receivable	0
Prepaid expenses and other	-14.75K
Accounts payable & accrued liabilities	105.34K
Increase (Decrease) in related party	212.65K
Deferred revenue	0
Subscriptions receivable	0
Net Cash Used in Operating Activities	-1.55M
Net proceeds from notes receivable	0
Patent costs	-48.73K
Proceeds from sale of investment securities	0
Net Cash Used in Investing Activities	-64.92K
Due to related parties	0
Proceeds from loans payable	0
Repayment on loans payable	0
Proceeds from convertible debt	78.5K
Repayment on convertible debt	-18.84K
Deferred financing costs	0
Debt issue costs	-3.5K
Proceeds from shares issued of common stock	0
Proceeds from the exercise of stock options and warrants	2.29K
Share Issuance costs	0
Net Cash Provided by Financing Activities	38.45K
Net (Decrease) Increase in Cash	-1.58M
Cash- Beginning of period	1.77M
Cash - End of period	189.15K
Share issued to settle debt and services	174.8K
Units issued as share issuance costs	0
Note payable converted into common shares	0
Interest paid	55.31K
Income taxes	0

This is a StreetInsider.com Premium Only Page